Experimental manipulations of afferent immune responses influence efferent immune responses to brain tumors

Cancer Immunology, Immunotherapy

Volumn 57, Issue 9, 2008, Pages 1323-1333

  Thomas, Diana L ^a   Kranz, David M ^a   Roy, Edward J ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Brain tumors; Immune privilege; Immunotherapy; Lymph nodes; T cells

Indexed keywords

TUMOR ANTIGEN;

AFFERENT IMMUNE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BONE MARROW CELL; BRAIN TUMOR; BRAIN VENTRICLE TUMOR; CANCER CELL; CANCER CELL CULTURE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CERVICAL LYMPH NODE; CONTROLLED STUDY; CYTOTOXICITY; EFFERENT IMMUNE RESPONSE; EXPERIMENTAL STUDY; IMMUNE RESPONSE; IMMUNOGENICITY; INFUSION SYSTEM; ISOTOPE LABELING; KIDNEY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; SPLEEN; SURVIVAL TIME; T LYMPHOCYTE; TUMOR VOLUME;

ANIMALS; BRAIN NEOPLASMS; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; LYMPH NODES; LYMPHATIC METASTASIS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; TIME FACTORS;

EID: 45849084617     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-008-0467-8     Document Type: Article

References (28)

1. Alvarez D, Swirski FK, Yang TC, Fattouh R, Croitoru K, Bramson JL, Stampfli MR, Jordana M (2006) Inhalation tolerance is induced selectively in thoracic lymph nodes but executed pervasively at distant mucosal and nonmucosal tissues. J Immunol 176:2568-2580
2. Barbey C, Donatelli-Dufour N, Batard P, Corradin G, Spertini F (2004) Intranasal treatment with ovalbumin but not the major T cell epitope ovalbumin 323-339 generates interleukin-10 secreting T cells and results in the induction of allergen systemic tolerance. Clin Exp Allergy 34:654-662
3. Bauer J, Bradl M, Hickley WF, Forss-Petter S, Breitschopf H, Linington C, Wekerle H, Lassmann H (1998) T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition. Am J Pathol 153:715-724
4. Cho BK, Palliser D, Guillen E, Wisniewski J, Young RA, Chen J, Eisen HN (2000) A proposed mechanism for the induction of cytotoxic T lymphocyte production by heat shock fusion proteins. Immunity 12:263-272
5. Cserr HF, Knopf PM (1992) Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol Today 13:507-512
6. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH (2000) Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 1:119-126
7. Ezernitchi AV, Vaknin I, Cohen-Daniel L, Levy O, Manaster E, Halabi A, Pikarsky E, Shapira L, Baniyash M (2006) TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs. J Immunol 177:4763-4772
8. Galea I, Bechmann I, Perry VH (2007) What is immune privilege (not)? Trends Immunol 28:12-8. Epub 2006 Nov 28
9. Gordon LB, Knopf PM, Cserr HF (1992) Ovalbumin is more immunogenic when introduced into brain or cerebrospinal fluid than into extracerebral sites. J Neuroimmunol 40:81-87
10. Gordon LB, Nolan SC, Cserr HF, Knopf PM, Harling-Berg CJ (1997) Growth of P511 mastocytoma cells in BALB/c mouse brain elicits CTL response without tumor elimination: a new tumor model for regional central nervous system immunity. J Immunol 159:2399-2408
11. Graf MR, Sauer JT, Merchant RE (2005) Tumor infiltration by myeloid suppressor cells in response to T cell activation in rat gliomas. J Neurooncol 73:29-36
12. Harling-Berg CJ, Park TJ, Knopf PM (1999) Role of the cervical lymphatics in the Th2-type hierarchy of CNS immune regulation. J Neuroimmunol 101:111-127
13. Ichimura T, Fraser PA, Cserr HF (1991) Distribution of extracellular tracers in perivascular spaces of the rat brain. Brain Res 545:103-113
14. Itano AA, McSorley SJ, Reinhardt RL, Ehst BD, Ingulli E, Rudensky AY, Jenkins MK (2003) Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19:47-57
15. Johnston JV, Malacko AR, Mizuno MT, McGowan P, Hellstrom I, Hellstrom KE, Marquardt H, Chen L (1996) B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes. J Exp Med 183:791-800
16. Kida S, Pantazis A, Weller RO (1993) CSF drains directly from the subarachnoid space into nasal lymphatics in the rat - anatomy, histology and immunological significance. Neuropathology and Applied Neurobiology 19:480-488
17. Malarkannan S, Shih PP, Eden PA, Horng T, Zuberi AR, Christianson G, Roopenian D, Shastri N (1998) The molecular and functional characterization of a dominant minor H antigen, H60. J Immunol 161:3501-3509
18. Masson F, Calzascia T, Di Berardino-Besson W, de Tribolet N, Dietrich PY, Walker PR (2007) Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cells. J Immunol 179:845-853
19. Munn DH, Mellor AL (2006) The tumor-draining lymph node as an immune-privileged site. Immunol Rev 213:146-158
20. Okamoto Y, Yamashita J, Hasegawa M, Fujisawa H, Yamashima T, Hashimoto T, Nonomura A, Matsumoto Y, Kida S (1999) Cervical lymph nodes play the role of regional lymph nodes in brain tumour immunity in rats. Neuropathol Appl Neurobiol 25:113-122
21. Roy EJ, Gawlick U, Orr BA, Rund LA, Webb AG, Kranz DM (2000) IL-12 treatment of endogenously arising murine brain tumors. J Immunol 165:7293-7299
22. Shirai Y (1921) On the transplantation of the rat sarcoma in adult heterogenous animals. Jpn Med World 1:14-15
23. Stevenson PG, Hawke S, Sloan DJ, Bangham CRM (1997) The immunogenicity of intracerebral virus infection depends on anatomical site. J Virol 71:145-151
24. Unger WW, Jansen W, Wolvers DA, van Halteren AG, Kraal G, Samsom JN (2003) Nasal tolerance induces antigen-specific CD4+CD25- regulatory T cells that can transfer their regulatory capacity to naive CD4+ T cells. Int Immunol 15:731-739
25. Widner H, Moller G, Johansson BB (1988) Immune response in deep cervical lymph nodes and spleen in the mouse after antigen deposition in different intracerebral sites. Scand J Immunol 28:563-571
26. Winkler B, Hufnagl K, Spittler A, Ploder M, Kallay E, Vrtala S, Valenta R, Kundi M, Renz H, Wiedermann U (2006) The role of Foxp3+ T cells in long-term efficacy of prophylactic and therapeutic mucosal tolerance induction in mice. Allergy 61:173-180
27. Wolvers DA, Coenen-de Roo CJ, Mebius RE, van der Cammen MJ, Tirion F, Miltenburg AM, Kraal G (1999) Intranasally induced immunological tolerance is determined by characteristics of the draining lymph nodes: studies with OVA and human cartilage gp-39. J Immunol 162:1994-1998
28. Yamada S, DePasquale M, Patlak CS, Cserr HF (1991) Albumin outflow into deep cervical lymph from different regions of rabbit brain. Am J Physiol 261:H1197-H1204